Live Breaking News & Updates on Oxford Science Enterprise
Stay updated with breaking news from Oxford science enterprise. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oxford, UK-based OMass Therapeutics closed on a $100 million Series B financing round. The round was led by new investors GV (formerly Google Ventures), Northpond Ventures and Sanofi Ventures. Three existing investors also participated: Syncona, Oxford Science Enterprise and Oxford University. ....
OXFORD, England, April 19, 2022 /PRNewswire/ Oxford Science Enterprises, the Science Business Builder which transforms world-leading science from the University of Oxford into world-changing ....
/PRNewswire/ Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of Oxford, announces it has entered. ....
/PRNewswire/ Oxford Science Enterprises, the Science Business Builder and preferred intellectual property partner of the University of Oxford, today. ....
- Craig Fox PhD, former CSO of C4X Discovery joins as Operating Partner, Life Sciences - Caroline Cake MBA, MEng, former CEO of Health Data Research UK, joins as Entrepreneur in Residence ....